聯合醫務(00722.HK)中期扭虧為盈至4555.1萬港元
格隆匯2月26日丨聯合醫務(00722.HK)公佈,截至2019年12月31日止六個月,實現收入3.07億港元,同比增長17.2%;公司擁有人應占期內利潤4555.1萬港元,去年同期虧損1650.1萬港元;基本每股盈利6.046港仙;擬派中期股息每股0.65港仙。
公告顯示,醫療收入方面,向合約客户提供醫療服務的收入由2019財政年度上半年1.115億港元增加4.8%至2020財政年度上半年1.167億港元,乃主要由於尋求醫療服務的患者就診次數及次均診費增加。
據悉,來自內地保健業務的收入由2019財政年度上半年2440萬港元增至2020財政年度上半年2770萬港元,乃主要由於為到海外留學或工作的中國居民提供的體檢次數以及為企業僱員及保險計劃成員提供的體檢次數增加。
此外,專業服務費用由2019財政年度上半年1.07億港元增加14.1%至2020財政年度上半年1.22億港元,主要由於醫生、牙醫及其他專業人士提供服務的成本增加。該增長百分比一般與集團於2020財政年度上半年的綜合收入增加一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.